Tsukasa Ohmori

4.4k total citations
108 papers, 3.2k citations indexed

About

Tsukasa Ohmori is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Tsukasa Ohmori has authored 108 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 41 papers in Hematology and 29 papers in Genetics. Recurrent topics in Tsukasa Ohmori's work include Virus-based gene therapy research (26 papers), Platelet Disorders and Treatments (24 papers) and CAR-T cell therapy research (20 papers). Tsukasa Ohmori is often cited by papers focused on Virus-based gene therapy research (26 papers), Platelet Disorders and Treatments (24 papers) and CAR-T cell therapy research (20 papers). Tsukasa Ohmori collaborates with scholars based in Japan, United States and Brazil. Tsukasa Ohmori's co-authors include Yutaka Yatomi, Yoichi Sakata, Jun Mimuro, Seiji Madoiwa, Yukio Ozaki, Yuji Kashiwakura, Akira Ishiwata, Makoto Osada, Yasuyuki Igarashi and Asuka Sakata and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Tsukasa Ohmori

103 papers receiving 3.2k citations

Peers

Countries citing papers authored by Tsukasa Ohmori

Since Specialization

Citations

This map shows the geographic impact of Tsukasa Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsukasa Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsukasa Ohmori more than expected).

Fields of papers citing papers by Tsukasa Ohmori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsukasa Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsukasa Ohmori. The network helps show where Tsukasa Ohmori may publish in the future.

Co-authorship network of co-authors of Tsukasa Ohmori

This figure shows the co-authorship network connecting the top 25 collaborators of Tsukasa Ohmori. A scholar is included among the top collaborators of Tsukasa Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsukasa Ohmori. Tsukasa Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy 2025 ·Blood ·Yuji Kashiwakura, Yuto Nakajima, (unknown), Tiago J. S. Lopes, (unknown), Yuki Yamaguchi, (unknown), Morisada Hayakawa, Yuko Katakai, Susumu Uchiyama, Osamu Nureki, Keiji Nogami, Tsukasa Ohmori	0
2	Glycosylation of recombinant adeno-associated virus serotype 6 2024 ·Molecular Therapy — Methods & Clinical Development ·Yuki Yamaguchi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yasuo Tsunaka, (unknown), (unknown), Tetsuo Torisu, (unknown), (unknown), Saho Mizukado, (unknown), Yuji Kashiwakura, Tsukasa Ohmori, (unknown), Susumu Uchiyama	5
3	The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential 2024 ·Blood Advances ·Yuto Nakajima, (unknown), (unknown), Yuji Kashiwakura, Tsukasa Ohmori, Keiji Nogami	1
4	Cure of Congenital Purpura Fulminans via Expression of Engineered Protein C Through Neonatal Genome Editing in Mice 2024 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), (unknown), Yasumitsu Nagao, Yuji Kashiwakura, Morisada Hayakawa, (unknown), Takayuki Fujiwara, Eriko Morishita, Osamu Nureki, Tsukasa Ohmori	1
5	Genome Editing of Murine Liver Hepatocytes by AAV Vector-Mediated Expression of Cas9 In Vivo 2023 ·Methods in molecular biology ·Yuji Kashiwakura, Tsukasa Ohmori	2
6	PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells 2023 ·SHILAP Revista de lepidopterología ·(unknown), Yuji Kashiwakura, Morisada Hayakawa, (unknown), Nobuhiko Kamoshita, (unknown), Hiroshi Inaba, Hiroshi Nishimasu, Hideki Uosaki, Yutaka Hanazono, Osamu Nureki, Tsukasa Ohmori	14
7	Advances in gene therapy for hemophilia 2021 ·Japanese Journal of Thrombosis and Hemostasis ·Yuji Kashiwakura, Tsukasa Ohmori	2
8	Deletion of inflammasome adaptor protein ASC enhances functional recovery after spinal cord injury in mice 2020 ·Journal of Orthopaedic Science ·Yasuyuki Shiraishi, Atsushi Kimura, Hiroaki Kimura, Tsukasa Ohmori, Masafumi Takahashi, Katsushi Takeshita	11
9	Establishment of a megakaryoblastic cell line for conventional assessment of platelet calcium signaling 2020 ·International Journal of Hematology ·Hiroshi Saitō, Morisada Hayakawa, Nobuhiko Kamoshita, Atsushi Yasumoto, Katsue Suzuki‐Inoue, Yutaka Yatomi, Tsukasa Ohmori	2
10	Safety of intra-articular transplantation of lentivirally transduced mesenchymal stromal cells for haemophilic arthropathy in a non-human primate 2018 ·International Journal of Hematology ·Tsukasa Ohmori, Hiroaki Mizukami, Yuko Katakai, (unknown), (unknown), Makoto Inoue, Tsugumine Shu, Hideharu Sugimoto, Yoichi Sakata	9
11	Genetically Modified Adipose Tissue-Derived Stem/Stromal Cells, Using Simian Immunodeficiency Virus-Based Lentiviral Vectors, in the Treatment of Hemophilia B 2013 ·Human Gene Therapy ·Natsumi Watanabe, Kazuo Ohashi, Kohei Tatsumi, Rie Utoh, In Kyong Shim, (unknown), Yuji Kashiwakura, Tsukasa Ohmori, Yoichi Sakata, Makoto Inoue, Mamoru Hasegawa, Teruo Okano	15
12	The prevalence of neutralizing antibodies against adeno‐associated virus capsids is reduced in young Japanese individuals 2013 ·Journal of Medical Virology ·Jun Mimuro, Hiroaki Mizukami, Midori Shima, Tadashi Matsushita, Masashi Taki, (unknown), Satoshi Higasa, Michio Sakai, Tsukasa Ohmori, Seiji Madoiwa, Keiya Ozawa, Yoichi Sakata	62
13	Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis 2013 ·Journal of Critical Care ·Kansuke Koyama, Seiji Madoiwa, Shinichiro Tanaka, Toshitaka Koinuma, Masahiko Wada, Asuka Sakata, Tsukasa Ohmori, Jun Mimuro, Shin Nunomiya, Yoichi Sakata	15
14	Mutant Macaque Factor IX T262A: A Tool for Hemophilia B Gene Therapy Studies in Macaques 2010 ·Thrombosis Research ·Akira Ishiwata, Jun Mimuro, Hiroaki Mizukami, Yuji Kashiwakura, Atsushi Yasumoto, Asuka Sakata, Tsukasa Ohmori, Seiji Madoiwa, Fumiko Ono, Midori Shima, Akira Yoshioka, Keiya Ozawa, Yoichi Sakata	2
15	Platelets and Laboratory Medicine 2008 ·Japanese Journal of Thrombosis and Hemostasis ·Tsukasa Ohmori	0
16	A classification of the fibrin network structures formed from the hereditary dysfibrinogens 2006 ·Journal of Thrombosis and Haemostasis ·Teruko Sugo, Hitoshi Endo, Michio Matsuda, Tsukasa Ohmori, Seiji Madoiwa, Jun Mimuro, Yoichi Sakata	25
17	Plasminogen Activator Inhibitor 1 Promotes a Poor Prognosis in Sepsis-Induced Disseminated Intravascular Coagulation 2006 ·International Journal of Hematology ·Seiji Madoiwa, Shin Nunomiya, Tomoko Ono, (unknown), Tsukasa Ohmori, Jun Mimuro, Yoichi Sakata	100
18	Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients 2006 ·Journal of Thrombosis and Haemostasis ·Tsukasa Ohmori, Yutaka Yatomi, (unknown), Yoshinao Kobayashi, Seiji Madoiwa, Jun Mimuro, Yukio Ozaki, Yoichi Sakata	95
19	Differential activation and redistribution of c-Src and Fyn in platelets, assessed by MoAb specific for C-terminal tyrosine-dephosphorylated c-Src and Fyn 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Yi Wu, Yukio Ozaki, (unknown), (unknown), Tsukasa Ohmori, Yutaka Yatomi, (unknown)	21
20	[Hemodynamic effects of acetate on the cardiovascular system (author's transl)]. 1978 ·PubMed ·Yoshiyasu Aizawa, (unknown), Tsukasa Ohmori, Yoshihei Hirasawa	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact